These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10857826)

  • 1. Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
    Loewenstein A; Humayun MS; de Juan E; Campochiaro PA; Haller JA
    Ophthalmology; 2000 Jun; 107(6):1078-82. PubMed ID: 10857826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair.
    Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ; Schiffman JC
    Ophthalmology; 2000 May; 107(5):860-5. PubMed ID: 10811075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group.
    Soheilian M; Peyman GA; Wafapoor H; Navarro GC; Thompson H
    Int Ophthalmol; 1996-1997; 20(5):241-9. PubMed ID: 9112194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group.
    Kertes PJ; Wafapoor H; Peyman GA; Calixto N; Thompson H
    Ophthalmology; 1997 Jul; 104(7):1159-65. PubMed ID: 9224470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane.
    Scott IU; Murray TG; Flynn HW; Feuer WJ; Schiffman JC;
    Ophthalmology; 2002 Oct; 109(10):1828-33. PubMed ID: 12359602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Perfluro-N-Octane tamponade for complex retinal detachment surgery.
    Reza AT
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):63-9. PubMed ID: 26415342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy.
    Coll GE; Chang S; Sun J; Wieland MR; Berrocal MH
    Ophthalmology; 1995 Apr; 102(4):630-8; discussion 638-9. PubMed ID: 7724180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment.
    Imaizumi A; Kusaka S; Noguchi H; Shimomura Y; Sawaguchi S
    Am J Ophthalmol; 2014 Feb; 157(2):384-389.e2. PubMed ID: 24332376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of traumatic retinal detachment with vitreon in children.
    Cekiç O; Batman C; Totan Y; Aslan O; Ozalp S
    Int Ophthalmol; 1999; 23(3):145-8. PubMed ID: 11456251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon). Vitreon Study Group.
    Carroll BF; Peyman GA; Mehta NJ; Millsap CM; Greve MD; Dunlap WA; Lee KJ; Ma PE
    Can J Ophthalmol; 1994 Apr; 29(2):66-9. PubMed ID: 8069756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
    Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ
    Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroperhydrophenanthrene (Vitreon) as a short-term vitreous substitute after complex vitreoretinal surgery.
    Tanji TM; Peyman GA; Mehta NJ; Millsap CM
    Ophthalmic Surg; 1993 Oct; 24(10):681-5. PubMed ID: 8259246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative perfluoro-N-octane tamponade for primary retinal detachment repair.
    Rush R; Sheth S; Surka S; Ho I; Gregory-Roberts J
    Retina; 2012 Jun; 32(6):1114-20. PubMed ID: 21968506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery.
    Garcia-Valenzuela E; Ito Y; Abrams GW
    Retina; 2004 Oct; 24(5):746-52. PubMed ID: 15492629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of perfluorocarbon liquids in vitreoretinal surgery.
    Crafoord S; Larsson J; Hansson LJ; Carlsson JO; Stenkula S
    Acta Ophthalmol Scand; 1995 Oct; 73(5):442-5. PubMed ID: 8751125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon).
    Schulman JA; Peyman GA; Blinder KJ; Alturki WA; Desai UR; Nelson NC
    Jpn J Ophthalmol; 1993; 37(1):70-7. PubMed ID: 8320868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure changes in the vitreon study.
    Batman C; Cekiç O; Totan Y; Aslan O; Ozalp S
    Ophthalmic Surg Lasers; 1999; 30(9):721-6. PubMed ID: 10574493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars plana vitrectomy with medium-term postoperative perfluoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy.
    Sigler EJ; Randolph JC; Calzada JI; Charles S
    Retina; 2013 Apr; 33(4):791-7. PubMed ID: 23117281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreon, a new perfluorocarbon.
    Blinder KJ; Peyman GA; Paris CL; Dailey JP; Alturki W; Lui KR; Gremillion CM; Clark LC
    Br J Ophthalmol; 1991 Apr; 75(4):240-4. PubMed ID: 2021595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.